Skip to main content

Investing

By Sophie Porter | 04:00 am | October 07, 2020
British integrated optics solutions company Rockley Photonics have raised $50 million in growth funding led by Credit Suisse-backed SIG-i Capital and the venture capital arm of Applied Materials Inc., Applied Ventures, LLC. The optics solutions provider also received backing from deep-tech VCs, institutional funds, strategic investors and existing shareholders.
By Mallory Hackett | 01:43 pm | October 06, 2020
The deal rates Clover at an enterprise value of about $3.7 billion and is expected to close in early 2021.
By Dave Muoio | 01:09 pm | October 06, 2020
Like others in the space, the 43-year-old owner of the NordicTrack, Freemotion, ProForm and iFit brands has seen revenues rise amidst social distancing.
By Tammy Lovell | 03:38 am | October 06, 2020
Investment proceeds will primarily fund FDA registration studies and opening of US headquarters.
By Dean Koh | 12:37 am | October 06, 2020
Founded in 2015, Malaysia-based corporate healthcare benefits and wellness management platform HealthMetrics last week announced it has raised a total of $5 million (approximately RM 20 million) as part of its Series A funding.
By Dave Muoio | 02:49 pm | October 05, 2020
Rock Health reports $4 billion in funding for U.S. digital health startups this quarter, much of which was driven by a flurry of telehealth investments and late-stage rounds for R&D and fitness tech companies.
By Laura Lovett | 01:07 pm | October 05, 2020
The funding was invested by fellow health company Reckitt Benckiser. 
By Dave Muoio | 03:39 pm | October 01, 2020
The newly announced deal is expected to close in Q4 2020, and values the direct-to-consumer telehealth company's combined entity at $1.6 billion.
By Dave Muoio and Laura Lovett | 02:20 pm | October 01, 2020
Also European virtual care company HomeDoctor scores $4.3M and sexual health company Emjoy closes seed funding round. 
By Tammy Lovell | 09:39 am | October 01, 2020
The funds will support global expansion to meet growing clinical and biopharma demand for data-driven medicine.